Phase 2 Readout~quarter
Phase 2 Readout: qrx003
- Drug
- qrx003
- Indication
- Netherton Syndrome
Other upcoming events for QNRX
Phase 3 ReadoutPhase 3 Topline: A Single Center, Open Label, Expanded Access Study of QRX003 Lotion in Subjects With Netherton Syndr
Phase 3 ReadoutPhase 3 Topline: A Multicenter, Randomized, Vehicle-Controlled, Double-Blind, Parallel Comparison Study of QRX003 Lot
Phase 3 ReadoutPhase 3 Topline: A Multicenter, Open-label Study of QRX003 Lotion in Participants With Netherton Syndrome
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.